Cargando…

Immune biomarkers of treatment failure for a patient with renal cell carcinoma on a Phase I trial of pembrolizumab plus radiotherapy

Detalles Bibliográficos
Autores principales: Alexander, Gregory, Palmer, Joshua, Tuluc, Madalina, Lin, Jianqing, Hooper, D Craig, Lu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645293/
http://dx.doi.org/10.1186/2051-1426-3-S2-P143
_version_ 1782400801137754112
author Alexander, Gregory
Palmer, Joshua
Tuluc, Madalina
Lin, Jianqing
Hooper, D Craig
Lu, Bo
author_facet Alexander, Gregory
Palmer, Joshua
Tuluc, Madalina
Lin, Jianqing
Hooper, D Craig
Lu, Bo
author_sort Alexander, Gregory
collection PubMed
description
format Online
Article
Text
id pubmed-4645293
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46452932015-11-20 Immune biomarkers of treatment failure for a patient with renal cell carcinoma on a Phase I trial of pembrolizumab plus radiotherapy Alexander, Gregory Palmer, Joshua Tuluc, Madalina Lin, Jianqing Hooper, D Craig Lu, Bo J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645293/ http://dx.doi.org/10.1186/2051-1426-3-S2-P143 Text en Copyright © 2015 Alexander et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Alexander, Gregory
Palmer, Joshua
Tuluc, Madalina
Lin, Jianqing
Hooper, D Craig
Lu, Bo
Immune biomarkers of treatment failure for a patient with renal cell carcinoma on a Phase I trial of pembrolizumab plus radiotherapy
title Immune biomarkers of treatment failure for a patient with renal cell carcinoma on a Phase I trial of pembrolizumab plus radiotherapy
title_full Immune biomarkers of treatment failure for a patient with renal cell carcinoma on a Phase I trial of pembrolizumab plus radiotherapy
title_fullStr Immune biomarkers of treatment failure for a patient with renal cell carcinoma on a Phase I trial of pembrolizumab plus radiotherapy
title_full_unstemmed Immune biomarkers of treatment failure for a patient with renal cell carcinoma on a Phase I trial of pembrolizumab plus radiotherapy
title_short Immune biomarkers of treatment failure for a patient with renal cell carcinoma on a Phase I trial of pembrolizumab plus radiotherapy
title_sort immune biomarkers of treatment failure for a patient with renal cell carcinoma on a phase i trial of pembrolizumab plus radiotherapy
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645293/
http://dx.doi.org/10.1186/2051-1426-3-S2-P143
work_keys_str_mv AT alexandergregory immunebiomarkersoftreatmentfailureforapatientwithrenalcellcarcinomaonaphaseitrialofpembrolizumabplusradiotherapy
AT palmerjoshua immunebiomarkersoftreatmentfailureforapatientwithrenalcellcarcinomaonaphaseitrialofpembrolizumabplusradiotherapy
AT tulucmadalina immunebiomarkersoftreatmentfailureforapatientwithrenalcellcarcinomaonaphaseitrialofpembrolizumabplusradiotherapy
AT linjianqing immunebiomarkersoftreatmentfailureforapatientwithrenalcellcarcinomaonaphaseitrialofpembrolizumabplusradiotherapy
AT hooperdcraig immunebiomarkersoftreatmentfailureforapatientwithrenalcellcarcinomaonaphaseitrialofpembrolizumabplusradiotherapy
AT lubo immunebiomarkersoftreatmentfailureforapatientwithrenalcellcarcinomaonaphaseitrialofpembrolizumabplusradiotherapy